Rxaminer
About Rxaminer
Rxaminer operates as a technology company in the pharmaceutical sector, leveraging artificial intelligence to process clinical trial data and identify drug repurposing opportunities. Services include predictive analytics for research and development, enabling faster evaluation of therapeutic potentials. The platform supports global pharmaceutical entities by aggregating and interpreting vast datasets from regulatory sources. Founded details are not specified, with operations centered on digital tools rather than physical locations.
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
DestinationRx
(May 05, 2006)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Rxaminer
Detailed funding history for Rxaminer
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Rxaminer
Rxaminer has secured backing from 1 investor. Prominent investors backing the company include ConnectureDRX.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Web-based prescription drug and Medicare plan comparisons are provided.
|
Locked | Locked | Locked |
Investor details for Rxaminer
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rxaminer
Investment portfolio details for Rxaminer
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rxaminer
Detailed financials for Rxaminer
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rxaminer Comparisons
Peer comparison for Rxaminer
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rxaminer
Detailed competitors of Rxaminer
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rxaminer
Complete news archive for Rxaminer
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rxaminer
Rxaminer operates as a technology company in the pharmaceutical sector, leveraging artificial intelligence to process clinical trial data and identify drug repurposing opportunities. Services include predictive analytics for research and development, enabling faster evaluation of therapeutic potentials. The platform supports global pharmaceutical entities by aggregating and interpreting vast datasets from regulatory sources. Founded details are not specified, with operations centered on digital tools rather than physical locations.
Rxaminer has 1 investor. Key investors include ConnectureDRX.